Nova Leap Health Corp.
NVLPF
$0.1803
-$0.0271-13.07%
OTC PK
| 03/31/2025 | 12/31/2024 | 09/30/2024 | 06/30/2024 | 03/31/2024 | |
|---|---|---|---|---|---|
| Revenue | 26.42M | 25.76M | 25.73M | 25.87M | 26.21M |
| Total Other Revenue | -- | -- | -- | -- | -- |
| Total Revenue | 26.42M | 25.76M | 25.73M | 25.87M | 26.21M |
| Cost of Revenue | 16.21M | 15.87M | 15.81M | 15.94M | 16.25M |
| Gross Profit | 10.21M | 9.89M | 9.92M | 9.94M | 9.96M |
| SG&A Expenses | 8.83M | 8.44M | 8.34M | 8.29M | 8.33M |
| Depreciation & Amortization | 630.30K | 583.80K | 625.10K | 683.50K | 801.40K |
| Other Operating Expenses | -- | -- | -- | -- | -- |
| Total Operating Expenses | 25.67M | 24.90M | 24.77M | 24.91M | 25.38M |
| Operating Income | 752.20K | 863.70K | 960.40K | 960.80K | 829.80K |
| Income Before Tax | 1.18M | 1.81M | -479.90K | 162.60K | -433.00K |
| Income Tax Expenses | 348.10K | 433.50K | -17.40K | 36.90K | -148.20K |
| Earnings from Continuing Operations | 0.83 | 1.38 | -0.46 | 0.13 | -0.28 |
| Earnings from Discontinued Operations | -- | -- | -- | -- | -- |
| Extraordinary Item & Accounting Change | -- | -- | -- | -- | -- |
| Minority Interest in Earnings | -- | -- | -- | -- | -- |
| Net Income | 827.10K | 1.38M | -462.50K | 125.80K | -284.70K |
| EBIT | 752.20K | 863.70K | 960.40K | 960.80K | 829.80K |
| EBITDA | 1.30M | 1.37M | 1.53M | 1.59M | 1.58M |
| EPS Basic | 0.01 | 0.02 | -0.01 | 0.00 | 0.00 |
| Normalized Basic EPS | 0.01 | 0.01 | 0.01 | 0.01 | 0.01 |
| EPS Diluted | 0.01 | 0.02 | -0.01 | 0.00 | 0.00 |
| Normalized Diluted EPS | 0.01 | 0.01 | 0.01 | 0.01 | 0.01 |
| Average Basic Shares Outstanding | 347.41M | 347.43M | 347.29M | 347.29M | 345.97M |
| Average Diluted Shares Outstanding | 348.67M | 348.70M | 348.55M | 348.28M | 346.96M |
| Dividend Per Share | -- | -- | -- | -- | -- |
| Payout Ratio | -- | -- | -- | -- | -- |